companydata.dkDraupnir Bio ApS: Financial statements 2025
CVR: 38546880
Draupnir Bio ApS (CVR 38546880) has filed annual accounts for 2025. Equity amounted to DKK 15,256,000. The solvency ratio was 39%. The company had 9 employees in the financial year.
- Equity
- 15,256,000 kr.
- Total Assets
- 39,072,000 kr.
- Employees
- 9
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | - | - | 15.3 mio. | 9 |
| 2024 | - | - | - | 27.6 mio. | 8 |
| 2023 | - | - | -41.2 mio. | 29.4 mio. | 10 |
| 2022 | - | - | -39.9 mio. | 18.6 mio. | 13 |
| 2021 | - | - | -67 mio. | 53.5 mio. | - |
Find more companies like Draupnir Bio ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2025
Draupnir Bio ApS has published its annual report for 2024.
About Draupnir Bio ApS
Draupnir Bio ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2017. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Andrew Thomas Hotchkiss. The company's owners include Novo Holdings A/S, Coöperatieve Gilde Healthcare IV U.A. and Danmarks Eksport- og Investeringsfond. Equity amounted to DKK 15,256,000.